Cite

    P. Levin et al.. “Therapeutically interchangeable? A study of real‐world outcomes associated with switching basal insulin analogues among US patients with type 2 diabetes mellitus using electronic medical records data.” Diabetes, obesity & metabolism, vol. 17, no. 3, n.d., pp. 245–253. http://access.bl.uk/ark:/81055/vdc_100025112897.0x000024